Conversely, patients with germline mutations in PTPN11 (NS) develop a myeloproliferative disorder that strongly resembles JMML, though nearly all cases appear to spontaneously regress over the first 18 months of life without a need for HCT (14, 37). This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.